Sign in

Jeri J. Harman

Non-Executive Chairman at NN
Board

About Jeri J. Harman

Independent non‑executive Chairman of NN, Inc.’s Board since January 4, 2021; director since February 2019; age 67. Founder and Chairman of Avante Capital Partners, with 40+ years of financing experience across >$2B of aggregate investments, focused on value creation, capital allocation, M&A, financial strategy, and board‑level governance .

Past Roles

OrganizationRoleTenureCommittees/Impact
Avante Capital PartnersFounder & ChairmanNot disclosedLed unitranche/sub debt/minority equity investing; firm recognized by SBA and PEWIN; deep capital allocation and M&A expertise applied to portfolio governance
Allied Capital (publicly traded PE/mezz fund)Los Angeles Office Founder; Investment Committee memberNot disclosedInvestment Committee role; leadership building West Coast presence and deal flow
American Capital (publicly traded PE/mezz fund)Los Angeles Office FounderNot disclosedStart‑up leadership; expanded origination platform

External Roles

OrganizationRoleTypeNotes
Avante Capital PartnersFounder & ChairmanPrivate investment firm>$900M AUM; SBIC and Women‑Owned Firm of the Year accolades
Various private companiesDirectorPrivate boardsService on boards of a number of private companies (names not disclosed)

Board Governance

  • Board leadership: Independent, non‑management Chairman; agenda‑setting and presiding over executive sessions of independent directors; separation of Chair and CEO deemed most appropriate; Harman facilitates Board–CEO communications .
  • Independence: Board determined Harman is independent under Nasdaq Rule 5605(a)(2); all standing committees are fully independent .
  • Committees: Compensation Committee member; Governance Committee member (not Chair) .
  • Attendance: Board met 8 times in 2024 with all independent directors in attendance; directors attended all committee meetings; all current directors attended the 2024 annual meeting . In 2023, Board met 9 times with all independent directors in attendance; all then‑current directors attended the 2023 annual meeting .
  • Executive sessions: Regular executive sessions of independent directors; all standing committees composed solely of independent directors .
CommitteeRole2024 Meetings
Compensation CommitteeMember5 meetings
Governance CommitteeMember5 meetings

Fixed Compensation

YearCash Retainer ($)Additional Chair/Committee Cash ($)Total Cash ($)Equity GrantEquity Grant Details
202480,000 75,000 (Non‑Exec Chairman retainer) 155,000 149,998 restricted stock 29,880 shares granted 3/19/2024; vest 1 year from grant
202380,000 75,000 (Non‑Exec Chairman retainer) 155,000 149,999 restricted stock 140,186 shares granted 4/1/2023; vest 1 year from grant

Notes:

  • Director compensation structure: no meeting fees disclosed; committee chair fees apply to other chairs (Audit $15k, Comp $12.5k, Governance $10k); Harman not a committee chair .
  • Annual non‑employee director program: $230,000 total target (cash + equity) plus role‑based premia; reviewed/approved by Compensation Committee .

Performance Compensation

ElementPresenceDetails
OptionsNot disclosed for directorsNo option awards disclosed in director compensation section/table
PSUs/Performance‑based equityNot disclosed for directorsDirector equity is time‑vested restricted stock; one‑year vesting; no performance metrics disclosed for directors
ClawbackPolicy applies to incentive compensationCompany maintains recoupment policy; primarily designed for executive incentive awards; equity awards under plans subject to clawback .

Other Directorships & Interlocks

CategoryDisclosure
Current public company boardsNone disclosed for Harman in NN proxy biography
Committee interlocks (Comp Committee)None; Compensation Committee comprised of independent non‑employees; no insider participation or interlocks disclosed .

Expertise & Qualifications

  • Capital allocation, M&A, financial strategy, risk management, balance sheet management; organizational development and strategic planning; portfolio board experience at private companies .
  • Brings investor/operator perspective to oversight and strategy as independent Chair .

Equity Ownership

HolderShares Beneficially OwnedPercent of ClassRecord Date Context
Jeri J. Harman308,265 <1% (“*”) Shares outstanding: 49,869,511 as of 3/17/2025

Ownership alignment policies:

  • Stock ownership guidelines: non‑employee directors must hold shares equal to 3× annual retainer; beneficial ownership includes RSUs (vested and unvested) .
  • Anti‑hedging/anti‑pledging: policy prohibits hedging and pledging by directors and officers; no pledging requests reported for NEOs to date .
  • Section 16 compliance: Company reported no director/executive Section 16(a) noncompliance for 2024; 2025 proxy notes no instances for covered persons .

Governance Assessment

  • Strengths supporting investor confidence:

    • Independent non‑executive Chair with deep investing/M&A credentials leading executive sessions and Board agenda; clear separation from CEO .
    • Committees fully independent; majority voting in uncontested elections; regular Board/committee self‑evaluations; reduced Board size for efficiency (9→7) .
    • Robust attendance and engagement across Board and committees; clear ESG oversight by Governance Committee .
    • Conservative director pay structure with time‑vested equity; reasonable premia for role‑based responsibilities .
    • Clawback policy, anti‑hedging/anti‑pledging, and ownership guidelines reinforce alignment and risk control .
    • No related‑party transactions disclosed; conflicts of interest controlled via Code of Conduct and Board oversight .
  • Potential watch‑items:

    • Director equity is time‑based (not performance‑based); alignment relies on ownership guidelines rather than explicit director‑level performance metrics .
    • No public company directorships disclosed for Harman (limits broad public board cross‑visibility, but reduces interlock risk) .
    • Say‑on‑pay context (executives): 87% support in 2024, signaling improved shareholder alignment versus prior year; continued monitoring warranted .